1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Senior stakeholders in the cardiopulmonary therapeutics sector are observing a rapidly evolving market for soluble guanylate cyclase stimulators, shaped by clinical innovation, policy shifts, and changing competitive strategies. In today’s environment, the ability to understand and act on market transformation is critical for ensuring effective product positioning and sustained business growth.
Market Snapshot: Soluble Guanylate Cyclase Stimulator Landscape
Soluble guanylate cyclase stimulators represent a pivotal advance in pulmonary hypertension care, leveraging a novel mechanism to amplify nitric oxide signaling and promote vasodilation. The market demonstrates strong momentum, supported by robust clinical evidence that highlights improved patient exercise capacity, reduced symptom burden, and notable progression in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension management. Accelerated regulatory pathways and adaptive trial endpoints further fuel adoption, while digital health integration and real-world outcome tracking are supporting broader deployment and payer engagement across primary markets.
Scope & Segmentation
This research provides a strategic breakdown of the soluble guanylate cyclase stimulator market, focusing on product differentiation, channel strategies, and region-specific developments.
- Product Type: Branded, Generic formulations
- Indication: Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension
- Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies (including Chain and Independent outlets)
- End User: Home Care Settings, Hospitals, Specialty Clinics
- Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, UAE, South Africa), Asia-Pacific (China, India, Japan, Australia, and others)
- Leading Companies: Bayer AG, Merck & Co., Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi S.A., Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Grünenthal GmbH, NOXXON Pharma N.V.
Key Takeaways for Senior Decision-Makers
- Sustained scientific innovation is driving the next generation of sGC stimulators, with an emphasis on improved pharmacokinetics and broadened patient safety profiles.
- Combination therapy strategies and expanded regulatory indications provide significant competitive differentiation and support for diverse patient segments.
- Strategic alliances—spanning licensing, co-development, and manufacturing optimization—accelerate pipeline progression and enable flexible market penetration.
- Digital tools enhance patient adherence while supporting robust post-marketing surveillance and health economics modeling; these technologies are pivotal to long-term value capture and stakeholder transparency.
- Regional market dynamics require adaptive go-to-market strategies that reflect differences in policy frameworks, infrastructure, and reimbursement pathways.
Tariff Impact: Supply Chain & Cost Structures in 2025
New US tariffs planned for 2025 are shaping procurement and production decisions for sGC stimulators. Tariff-driven input cost increases are prompting manufacturers to invest in domestic synthesis capabilities, pursue diversified supply agreements, and buffer inventory. Concurrently, payers and regulatory agencies are realigning pricing structures and reimbursement schemes to safeguard patient access despite cost volatility. Industry participants are adopting proactive risk-sharing agreements and value-based performance guarantees linked to measurable patient outcomes to mitigate tariff exposure.
Methodology & Data Sources
This research integrates primary and secondary data. Key opinion leader interviews, including pulmonologists and cardiologists, were combined with surveys of hospital and specialty clinic networks. Trends were validated through peer-reviewed publications, regulatory filings, clinical trial registries, and structured stakeholder feedback. The final analysis triangulates clinical and operational data to produce actionable, executive-level findings.
Why This Report Matters
- Delivers data-driven insights to inform portfolio management, resource allocation, and pipeline investment strategies.
- Maps evolving regulatory, competitive, and supply chain developments for sound risk mitigation and opportunity capture.
- Equips decision-makers to tailor market entry and expansion approaches, leveraging real-world evidence and innovation alignment.
Conclusion
The soluble guanylate cyclase stimulator market is defined by innovation, collaboration, and evolving policy frameworks. Executives who leverage data-driven insights and maintain flexibility in response to regional and regulatory shifts will be best positioned for sustainable growth and competitive advantage.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Clinical trial results demonstrating enhanced efficacy of sGC stimulators in heart failure with preserved ejection fraction
5.2. Regulatory approval pathways speeding market access for novel soluble guanylate cyclase stimulators in pulmonary hypertension
5.3. Emergence of combination therapies pairing sGC stimulators with phosphodiesterase inhibitors to improve patient outcomes
5.4. Advancements in oral formulation technology enhancing bioavailability and patient adherence to sGC stimulators
5.5. Competitive landscape shifts due to patent expirations and biosimilar entrants in the sGC stimulator market
5.6. Real-world evidence showing long-term safety profiles of sGC stimulators in diverse patient populations
5.7. Strategic partnerships between biopharma and technology firms for next-generation targeted sGC stimulator delivery systems
5.8. Pricing and reimbursement challenges affecting adoption rates of high-cost sGC stimulators in emerging markets
5.2. Regulatory approval pathways speeding market access for novel soluble guanylate cyclase stimulators in pulmonary hypertension
5.3. Emergence of combination therapies pairing sGC stimulators with phosphodiesterase inhibitors to improve patient outcomes
5.4. Advancements in oral formulation technology enhancing bioavailability and patient adherence to sGC stimulators
5.5. Competitive landscape shifts due to patent expirations and biosimilar entrants in the sGC stimulator market
5.6. Real-world evidence showing long-term safety profiles of sGC stimulators in diverse patient populations
5.7. Strategic partnerships between biopharma and technology firms for next-generation targeted sGC stimulator delivery systems
5.8. Pricing and reimbursement challenges affecting adoption rates of high-cost sGC stimulators in emerging markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Soluble Guanylate Cyclase Stimulators Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
8.2. Branded
8.3. Generic
9. Soluble Guanylate Cyclase Stimulators Market, by Indication
9.1. Introduction
9.2. Chronic Thromboembolic Pulmonary Hypertension
9.3. Pulmonary Arterial Hypertension
9.2. Chronic Thromboembolic Pulmonary Hypertension
9.3. Pulmonary Arterial Hypertension
10. Soluble Guanylate Cyclase Stimulators Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Soluble Guanylate Cyclase Stimulators Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Soluble Guanylate Cyclase Stimulators Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Soluble Guanylate Cyclase Stimulators Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Soluble Guanylate Cyclase Stimulators Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Merck & Co., Inc.
15.3.3. Johnson & Johnson
15.3.4. Novartis AG
15.3.5. Pfizer Inc.
15.3.6. Sanofi S.A.
15.3.7. Ironwood Pharmaceuticals, Inc.
15.3.8. Astellas Pharma Inc.
15.3.9. Grünenthal GmbH
15.3.10. NOXXON Pharma N.V.
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Merck & Co., Inc.
15.3.3. Johnson & Johnson
15.3.4. Novartis AG
15.3.5. Pfizer Inc.
15.3.6. Sanofi S.A.
15.3.7. Ironwood Pharmaceuticals, Inc.
15.3.8. Astellas Pharma Inc.
15.3.9. Grünenthal GmbH
15.3.10. NOXXON Pharma N.V.
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHAI
FIGURE 24. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHSTATISTICS
FIGURE 25. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHCONTACTS
FIGURE 26. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHAI
FIGURE 24. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHSTATISTICS
FIGURE 25. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHCONTACTS
FIGURE 26. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 67. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 74. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 75. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 84. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 85. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 136. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 137. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 166. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 167. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 246. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 247. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 276. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 277. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287.
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 67. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 74. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 75. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. CANADA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 84. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 85. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. MEXICO SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 136. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 137. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. GERMANY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. FRANCE SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 166. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 167. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ITALY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. SPAIN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. DENMARK SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. QATAR SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 246. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 247. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FINLAND SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 276. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 277. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. EGYPT SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. TURKEY SOLUBLE GUANYLATE CYCLASE STIMULATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287.
Samples
LOADING...
Companies Mentioned
The companies profiled in this Soluble Guanylate Cyclase Stimulators market report include:- Bayer AG
- Merck & Co., Inc.
- Johnson & Johnson
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Ironwood Pharmaceuticals, Inc.
- Astellas Pharma Inc.
- Grünenthal GmbH
- NOXXON Pharma N.V.
